SIGA News and Press, SIGA Technologies Inc. From 09/29/22

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Postmodern Studio / Shutterstock.com Lordstown Motors (NASDAQ: RIDE ) stock is sliding lower on Thursday even after announcing commercial production of its Endurance pickup truck. Production of the ele...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Matt Gush / Shutterstock.com Sobr Safe (NASDAQ: SOBR ) stock is falling on Friday after the company announced the pricing of a $6 million private placement . This private placement has institutional i...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s a great day to be invested in Siga Technologies  (NASDAQ: SIGA ) stock — or at least, it ought to be. The markets can be mysterious sometimes, though. Siga Technologies just disclosed a governm...

SIGA Technologies ( NASDAQ: SIGA ) notifies that the U.S. Department of Defense awarded a new contract to SIGA for the procurement of up to $10.7M of oral TPOXX, of which $5.1M of oral TPOXX is targeted for delivery in 2022 and the remainder is subject to an option at the sole...

NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Department of Defense (DoD) awarded a new contract to SIGA for the procurement of up to ...

SIGA Technologies ( NASDAQ: SIGA ) on Monday said it had got about $16M in international orders for its antiviral Tpoxx in Aug. and early Sept. in connection with the ongoing monkeypox outbreak. SIGA said it got approximately $10M in orders from the European Commission and $...

- Order for Approximately $10 Million Funded by the European Commission – - Orders for Approximately $6 Million Received from Two Countries in the Asia Pacific Region - NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a c...

Summary Global and regional cases of the 2022 monkeypox outbreak are on the downtrend. Barring another spike in cases, more orders for SIGA’s sole product TPOXX are unlikely. Less demand for TPOXX means a return to a valuation that relies more on stockpiling contracts. ...

So far, thankfully, the monkeypox outbreak isn't following in the footsteps of the coronavirus pandemic. In fact, new cases are even on the decline in the U.S. Still, companies' products to detect or treat this virus are much needed. The availability of such products may help slow or ev...

On Friday, the National Institutes of Health (NIH) announced the start of a late-stage clinical trial to test Siga Technologies’ ( NASDAQ: SIGA ) Tpoxx antiviral pill on monkeypox patients. Tpoxx, approved in the U.S. for related smallpox infection, is also used to ...